Implementation of Pharmaceutical Care Services During the COVID-19 Pandemic Worldwide
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: This study sought to research the implementation of pharmaceutical care services and review the pharmaceutical care services used for coronavirus disease 2019 (COVID-19) prevention, diagnosis, therapy, and vaccination during the COVID-19 pandemic. Methods: All articles reporting pharmacists’ implementation of pharmaceutical care services during the COVID-19 pandemic were comprehensively searched in PubMed/Medline, Embase, and the Cochrane Library databases up to July 7, 2021, then included in this study. Twenty-four items of pharmaceutical care services were classified into the following 5 categories: patient evaluation and monitoring, clinical decision support, compounding/dispensing/administration, patient consultation and education, and drug-related policy research and development. Results: A total of 674 articles from 100 countries were included, with the United States of America being the most frequently studied country. Across the 5 classified categories, compounding/dispensing/administration was most frequently examined (28.9%), followed by patient consultation and education (25.2%). Among the 24 items of pharmaceutical care services, medicine supply management was most frequently reported on (11.4%), followed by patient consultations (11.0%). The primary implemented pharmaceutical care services for COVID-19 prevention, diagnosis, therapy, and vaccination were public health education, COVID-19 testing services, medicine supply management, and vaccination, respectively. Conclusion: Pharmacists have implemented diverse pharmaceutical care services for COVID-19 prevention, diagnosis, therapy, and vaccination globally. Further studies should be conducted to determine the correlation between the characteristics of healthcare accessibility in a country and the implemented pharmaceutical care services for COVID-19.
Abstract
Background: This study sought to research the implementation of pharmaceutical care services and review the pharmaceutical care services used for coronavirus disease 2019 (COVID-19) prevention, diagnosis, therapy, and vaccination during the COVID-19 pandemic. Methods: All articles reporting pharmacists’ implementation of pharmaceutical care services during the COVID-19 pandemic were comprehensively searched in PubMed/Medline, Embase, and the Cochrane Library databases up to July 7, 2021, then included in this study. Twenty-four items of pharmaceutical care services were classified into the following 5 categories: patient evaluation and monitoring, clinical decision support, compounding/dispensing/administration, patient consultation and education, and drug-related policy research and development. Results: A total of 674 articles from 100 countries were included, with the United States of America being the most frequently studied country. Across the 5 classified categories, compounding/dispensing/administration was most frequently examined (28.9%), followed by patient consultation and education (25.2%). Among the 24 items of pharmaceutical care services, medicine supply management was most frequently reported on (11.4%), followed by patient consultations (11.0%). The primary implemented pharmaceutical care services for COVID-19 prevention, diagnosis, therapy, and vaccination were public health education, COVID-19 testing services, medicine supply management, and vaccination, respectively. Conclusion: Pharmacists have implemented diverse pharmaceutical care services for COVID-19 prevention, diagnosis, therapy, and vaccination globally. Further studies should be conducted to determine the correlation between the characteristics of healthcare accessibility in a country and the implemented pharmaceutical care services for COVID-19.
참고문헌 (25)
- "WHO Director-General’s opening remarks at the Mission briefing on COVID-19 - 12 March 2020"[URL]
- Parmasad V, "Physical distancing for care delivery in health care settings : Considerations and consequences", Am J Infect Control, 49(8), pp.1085~1088 (2021)
- Al-Tawfiq JA, "Changes in healthcare managing COVID and non-COVID-19 patients during the pandemic : striking the balance", Diagn Microbiol Infect Dis, 98(4), pp.115147~ (2020)
- "Implementation of mitigation strategies for communities with local COVID-19 transmission"[URL]
- "2019 Novel Coronavirus (2019-nCoV):Strategic preparedness and response plan"[URL]
- Pandey KR, "COVID-19 control strategies and intervention effects in resource limited settings : A modeling study", PLoS One, 16(6), pp.e0252570~ (2021)
- Berenguer B, "Pharmaceutical care : past, present and future", Curr Pharm Des, 10(31), pp.3931~3946 (2004)
- Goff DA, "Global contributions of pharmacists during the COVID-19 pandemic", J Am Coll Clin Pharm, 3(8), pp.1480~1492 (2020)
- Chahine EB, "The Role of Pharmacists in the Fight Against COVID-19", Sr Care Pharm, 35(7), pp.286~291 (2020)
- Merks P, "The legal extension of the role of pharmacists in light of the COVID-19 global pandemic", Res Social Adm Pharm, 17(1), pp.1807~1812 (2021)
- Andrade J, "Implementation of a pharmacist-led COVID-19 vaccination clinic at a community teaching hospital", Am J Health Syst Pharm, 78(12), pp.1038~1042 (2021)
- Schwerzmann J, "Evaluating the Impact of Pharmacies on Pandemic Influenza Vaccine Administration", Disaster Med Public Health Prep, 11(5), pp.587~593 (2017)
- Page MJ, "The PRISMA 2020 statement : an updated guideline for reporting systematic reviews", BMJ, 372, pp.n71~ (2021)
- "WHO Coronavirus (COVID-19) Dashboard"[URL]
- Pradhan D, "A Review of Current Interventions for COVID-19 Prevention", Arch Med Res, 51(5), pp.363~374 (2020)
- Howard J, "An evidence review of face masks against COVID-19", Proc Natl Acad Sci U S A, 118(4) (2021)
- Burki T, "Global shortage of personal protective equipment", Lancet Infect Dis, 20(7), pp.785~786 (2020)
- Cameron EE, "Analysis of drug shortages across two countries during pre-pandemic and pandemic times", Res Social Adm Pharm, 17(9), pp.1570~1573 (2021)
- "Coronavirus Disease 2019(COVID-19) Treatment Guidelines"[URL]
- Miller S, "Defining the pharmacist role in the pandemic outbreak of novel H1N1 influenza", J Am Pharm Assoc(2003), 52(6), pp.763~767 (2012)
- Mullen E, "Pandemic H1N1 influenza virus : academy perspectives on pharmacy's critical role in treatment, prevention", J Am Pharm Assoc(2003), 49(6), pp.722~728 (2009)
- Turale S, "Clinician mental health, nursing shortages and the COVID-19 pandemic : Crises within crises", Int Nurs Rev, 68(1), pp.12~14 (2021)
- Jones AM, "Burnout and secondary traumatic stress in health-system pharmacists during the COVID-19pandemic", Am J Health Syst Pharm, 78(9), pp.818~824 (2021)
- Isenor JE, "Impact of pharmacists as immunizers on vaccination rates : A systematic review and meta-analysis", Vaccine, 34(47), pp.5708~5723 (2016)
- Murray E, "Impact of pharmacy intervention on influenza vaccination acceptance : a systematic literature review and meta-analysis", Int J Clin Pharm, 43(5), pp.1163~1172 (2021)